Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
10 Patents
#200 in Seattle, WA
#684 in Washington
#29,839 in US
#55,986 in the World
Oncothyreon Inc.
Forward Citations = 58
15 inventors:
Seattle, WA, United States of America
Oncothyreon Inc.
% Expired Patents = 90.0
CIPO Patents = 1
EPO Patents = 9
Forward Citations = 58
Loading Chart...
Loading Chart...
15 inventors (with patents filed for the assignee):
B Michael Longenecker (5 out of 14 patents)
Wladyslaw A Budzynski (4 out of 4 patents)
R Rao Koganty (4 out of 7 patents)
4. Scott Peterson (2 out of 5 patents)
5. Linda Pestano (2 out of 2 patents)
6. Diana F Hausman (2 out of 4 patents)
7. Jeffrey Millard (2 out of 2 patents)
8. Sandy Koppenol (2 out of 3 patents)
9. Robert Kirkman (2 out of 2 patents)
10. Mark J Krantz (2 out of 3 patents)
11. Zi-Hua Jiang (2 out of 3 patents)
12. Zi-hua Jiang (1 out of 3 patents)
13. Damayanthi Yalamati (1 out of 3 patents)
14. Myung-Gi Baek (1 out of 1 patent)
15. Rao R Koganty (1 out of 3 patents)
10 patents:
Oncothyreon Inc. is a biotechnology company based in Seattle, Washington, specializing in the development of innovative cancer therapies. The organization focuses on harnessing the immune system to target and destroy cancer cells, with a commitment to advancing treatments for various types of cancer. Through its research, Oncothyreon aims to improve patient outcomes and contribute to the evolving landscape of oncology, leveraging cutting-edge technologies and scientific expertise in the field.
Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
1 patent (CIPO):
Please report any incorrect information to [email protected]
9 patents (EPO):
Please report any incorrect information to [email protected]